Kirkland & Ellis advised Eli Lilly, and Davis Polk advised the joint book-running managers for the offering.Eli Lilly and Company announced a registered offering of $4…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
